FR Weth, GB Hoggarth, AF Weth, E Paterson… - British Journal of …, 2024 - nature.com
High rates of failure, exorbitant costs, and the sluggish pace of new drug discovery and development have led to a growing interest in repurposing “old” drugs to treat both common …
Abstract Background and Aims Since its market release, gabapentin has been presumed to have no abuse potential and subsequently has been prescribed widely off‐label, despite …
J Langedijk, AK Mantel-Teeuwisse, DS Slijkerman… - Drug discovery today, 2015 - Elsevier
Highlights•Drug repositioning and similar terms have been a trending topic since 2004.•From a legal or regulatory perspective stimulation of drug repositioning requires …
The 21st Century Cures Act passed by the United States Congress mandates the US Food and Drug Administration to develop guidance to evaluate the use of real‐world evidence …
Importance Off-label use of prescription drugs has been identified as an important contributor to preventable adverse drug events (ADEs) in children. Despite concerns …
DrugCentral monitors new drug approvals and standardizes drug information. The current update contains 285 drugs (131 for human use). New additions include:(i) the integration of …
CM Wittich, CM Burkle, WL Lanier - Mayo Clinic Proceedings, 2012 - Elsevier
The term off-label drug use (OLDU) is used extensively in the medical literature, continuing medical education exercises, and the media. Yet, we propose that many health care …
Objective To examine off-label indications for antidepressants in primary care and determine the level of scientific support for off-label prescribing. Design Descriptive study of …